APOE and Alzheimer disease: Our hypothesis is that the APOE4-induced risk of AD is consistent with the following pathway to neurodegeneration: Compared to apoE3, apoE4-containing lipoproteins are less lipidated, which reduces stability, resulting in lower levels the apoE4/Aβ complex.